INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 30 April 2016
Net Assets |
£188m |
Net Assets per share |
489p |
Share price |
430p |
Total value of unquoted investments |
£20m |
Total number of portfolio companies |
86 |
Top Ten Holdings
Company Name |
% NAV |
Amgen |
8.2 |
Celgene |
6.6 |
Gilead |
6.1 |
Biogen |
5.9 |
Medivation |
5.0 |
Genmab |
3.7 |
Ophthotech |
3.2 |
Alexion |
3.2 |
Incyte |
2.9 |
Biomarin |
2.6 |
|
----------- |
Total |
47.4 |
Portfolio Revenue Split |
% NAV |
Revenue Generating |
71 |
Near Revenue |
4 |
No sales in the near term |
25 |
|
----------- |
Total |
100 |
Geographical Allocation |
% NAV |
US & Canada |
81 |
Europe & UK |
19 |
|
----------- |
Total |
100 |
Quoted/Unquoted Allocation |
% NAV |
Quoted |
89 |
Unquoted |
11 |
|
----------- |
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
24 MAY 2016